Elutia Inc. (ELUT)
NASDAQ: ELUT · IEX Real-Time Price · USD
3.745
-0.005 (-0.13%)
At close: Jul 26, 2024, 12:30 PM
3.880
+0.135 (3.60%)
After-hours: Jul 26, 2024, 4:41 PM EDT

Elutia Revenue

Elutia had revenue of $6.69M in the quarter ending March 31, 2024, with 4.72% growth. This brings the company's revenue in the last twelve months to $25.05M, up 33.61% year-over-year. In the year 2023, Elutia had annual revenue of $24.75M with 3.76% growth.

Revenue (ttm)
$25.05M
Revenue Growth
+33.61%
P/S Ratio
3.59
Revenue / Employee
$536,889
Employees
54
Market Cap
104.04M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202324.75M896.00K3.76%
Dec 31, 202223.85M-23.54M-49.68%
Dec 31, 202147.39M4.71M11.03%
Dec 31, 202042.68M-219.00K-0.51%
Dec 31, 201942.90M3.86M9.90%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Karyopharm Therapeutics 140.46M
CytomX Therapeutics 119.18M
TELA Bio 63.15M
Augmedix 48.70M
BrainsWay 34.26M
Adagene 18.11M
I-Mab 3.90M
Cardiff Oncology 610.00K
Revenue Rankings